BioMelbourne Network
BioMelbourne Network is a Victorian not-for-profit industry association, founded in 2001, that represents 200+ health technology member organisations and 6,000+ professionals across biotech, medtech, digital health, research, and government through tiered membership, events, and digital platforms.
- Company typePrivate
- Founded2001
- HeadquartersMelbourne, Australia
- Headcount1–10
- GTM typeB2B
- OfferingServices
What BioMelbourne Network does
BioMelbourne Network is an industry-led, not-for-profit membership association established in February 2001 by the Committee for Melbourne and incorporated on 1 July 2003. It operates as Victoria's peak body for the health technologies sector, representing more than 200 member organisations and approximately 6,000 professionals across biotechnology, medical technology, digital health, pharmaceuticals, and adjacent research and service industries. The organisation was founded in response to a Boston Consulting Group report identifying an expertise gap in Victoria's biotechnology sector, received a three-year Victorian Government establishment grant in late 2002, and has been financially independent since 2005, funded by membership fees and event activity.
The association's product and service portfolio spans a tiered membership programme (Corporate A$5,340, SME A$3,170, SME-Micro A$1,935, Professional A$1,580, Entrepreneur A$695, and Director A$152 per annum), signature events such as BioSymposiums and the annual Connecting Women Lunch (nearly 700 attendees), the Women in Leadership Awards (now in its 11th year), and a set of digital ecosystem platforms. These platforms include Wilam (an online health technologies community with 7,000+ professionals), BioResource Hub (on-demand learning content), Careers Hub (industry job board), and the Australian Medtech Manufacturing Alliance (AMMA). Content channels include the fortnightly 'In the Loop' newsletter (7,000+ subscribers), the BioMelbourne Network Podcast on Spotify and Apple, and a 16,000+ LinkedIn following.
Revenue is generated primarily through recurring annual membership subscriptions and event-driven income from registration fees and sponsorship (e.g., CSL Behring as major sponsor of Connecting Women Lunch, IQVIA Biotech as Thought Leader Partner for clinical trials BioSymposiums, RMIT and FB Rice for biosensing BioSymposiums). Two non-recurring LaunchVic grants (A$97,000 in September 2017 and A$114,000 in October 2018) supplemented early operating income. The organisation is governed by a Board of Directors, runs with a small core team of 4–10 staff based at Level 6, HWT Tower, 40 City Road, Southbank, Melbourne, and is currently led by Interim CEO Michelle Gallaher. Strategic activity includes international trade missions to Singapore and Asia-Pacific and joint advocacy with eight other Australian peak bodies on R&D Tax Incentive and capital gains tax reform.
BioMelbourne Network firmographics
Firmographics- Name
- BioMelbourne Network
- Legal name
- BioMelbourne Network
- Website
- https://biomelbourne.org
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- BioMelbourne Network is a Victorian not-for-profit industry association, founded in 2001, that represents 200+ health technology member organisations and 6,000+ professionals across biotech, medtech, digital health, research, and government through tiered membership, events, and digital platforms.
- Ownership category
- akta.pro rank
BioMelbourne Network industry classification
Industry- Product category
- Health Technology Industry Association
- NAICS
- Religious, Grantmaking, Civic, Professional, and Similar Organizations (813)
- SIC
- Services-Membership Organizations (8600)
- akta.pro primary industry
- Life Sciences & Biotechnology Congresses (THAHAJAB)
Keywords
Where BioMelbourne Network is headquartered
LocationHeadquarters
- HQ city
- Melbourne
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
BioMelbourne Network business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Membership Fees: Annual membership fees covering all employees within member organisations. Tiered pricing based on organisation size and type, from startups to large multinationals and universities.
- Event Registration Fees: Discounted member registration to all BioMelbourne Network events (in person and online), with non-member rates also available.
- Event Sponsorship: Event hosting and sponsorship opportunities tailored to members' interests and budget.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Corporate Membership for mid-to-large Australian enterprise and multinationals, universities, independent medical research institutes, government agencies and parent companies |
| Subscription | Annual | SME Membership for biotechnology and medical technology companies, SMEs, ASX listed companies with 100 or fewer employees |
| Subscription | Annual | SME-Micro Membership for established small/micro businesses employing 5 or fewer people |
| Subscription | Annual | Professional Membership for Sole Traders and independent freelance consultants supporting the sector |
| Subscription | Annual | Entrepreneur Membership for startup companies developing biotech, medtech, digital and healthcare products in pre-seed to seed stage, strictly pre-revenue |
| Subscription | Annual | Director Professional Membership for Sole Traders actively serving on the BioMelbourne Network Board |
Go-to-market motion1 record
Distribution channels4 records
Marketing channels8 records
BioMelbourne Network product offering
Product offeringCore offering
BioMelbourne Network is a not-for-profit, industry-led membership association that connects biotechnology, medical technology, and health innovation organisations in Victoria, Australia. It sells tiered annual memberships and delivers networking events, advocacy, and online community platforms (Wilam, BioResource Hub, Careers Hub) that foster collaboration, commercialisation, and policy engagement across the state's health technology ecosystem.
Product overview
BioMelbourne Network is an industry-led membership association for organizations engaged in biotechnology, medical technology, and health innovation in Victoria, Australia. Rather than a unified software product, it offers a portfolio of membership services, events programs, and online platforms. Membership programs provide networking, connections, and strategic updates across multiple tiers. Signature events include BioSymposium (sector conferences on topics like biosensing and clinical trials), the annual Connecting Women Lunch, and Women in Leadership Awards. Online platforms comprise Wilam (professional networking platform with 7,000+ members), BioResource Hub (on-demand learning), and Careers Hub (job board). Content services include a fortnightly 'In The Loop' newsletter (7,000+ subscribers) and podcast series. Trade missions connect Victorian companies with international markets. The organization also conducts advocacy and policy initiatives, including research publications like clinical trials white papers.
Differentiator
Problem solved
Functional benefit
Products and services
- Membership Programs Tiered annual industry membership for organisations engaged in biotechnology, medical technology, and health innovation in Victoria. Six tiers (Corporate $5,340, SME $3,170, SME-Micro $1,935, Professional $1,580, Entrepreneur $695, Director Professional $152) cover all employees within a member organisation and unlock networking, events, advocacy, and platform access.
- BioSymposium Events Signature paid symposium events that convene 100-150+ attendees to explore focused health technology topics such as 'Next-gen Biosensing' and 'Modernising clinical trials'. Members register at discounted rates; non-members pay higher rates. Sponsorship tiers include Major Sponsor, Thought Leader Partner, and Supporting Sponsor.
- Connecting Women Lunch Annual ticketed networking lunch celebrating women in health technologies, featuring keynote speakers, panel discussions, and recognition of sector achievements. Attracts nearly 700 attendees; sponsored by partners including CSL Behring.
- Wilam Community Platform
Quantifiable outcome
- Represents 200+ member organisations and 6,000+ professionals from local, national and international companies
- +4 more outcomes
Companies that use BioMelbourne Network
Customer profileNamed customers4 records
Segments4 records
Ideal customer profiles5 records
BioMelbourne Network technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
BioMelbourne Network partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered founding, core, major, supporting and minor.
- Committee for MelbournefoundingEstablished BioMelbourne Network in February 2001 following a Boston Consulting Group report on the Victorian biotechnology industry. Committee for Melbourne and BioMelbourne Network were successful in securing a three-year establishment grant from the State Government of Victoria in late 2002.
- AusBiotechcoreJoint advocacy partner on R&D Tax Incentive changes, representing Australia's biotech, medtech and health technology sector. Co-signatory on joint letters to Treasurer Jim Chalmers alongside seven other peak bodies.
- AusBiotech, BioNSW, Life Sciences Queensland, Life Sciences WA, Pathology Technology Australia, MTPConnect, ANDHealth, ARCS AustraliacoreNine peak health and medical technology industry bodies united in opposition to proposed R&D Tax Incentive changes and capital gains tax reforms, sending joint letter to Treasurer Jim Chalmers.
- Victorian Government (Department of Jobs, Skills, Industry and Regions)coreKey government partner supporting BioMelbourne Network initiatives including BioSymposiums as Premier Sponsor, establishment grant in 2002, and ongoing sector development programs.
- RMIT UniversitymajorMajor sponsor of BioSymposium 'Next-gen Biosensing' and collaborator on biosensing research translation initiatives.
- FB RicemajorMajor sponsor of BioSymposium 'Next-gen Biosensing'. Intellectual property consultancy supporting the health technology ecosystem.
- SeerPharmasupportingSupporting sponsor of BioSymposium 'Next-gen Biosensing' and contributor to regulatory and clinical trials discussions.
- IQVIA BiotechcoreThought Leader Partner for BioSymposium 'Modernising clinical trials', bringing expertise in clinical trial design and execution.
- PureCDMmajorMajor Sponsor for 'Modernising clinical trials' BioSymposium, supporting decentralised clinical trial discussions.
- Chubb Insurance AustraliasupportingSupporting sponsor for clinical trials BioSymposium, providing insurance expertise for clinical research sector.
- CSL BehringmajorMajor sponsor of the 2026 Connecting Women Lunch. CSL has been a longstanding supporter of the event with video presentations.
- Global VictoriacoreGovernment partner for trade missions to Singapore 2022, connecting Victorian health and medtech companies with international markets.
- Invest VictoriacorePartner for Singapore trade mission, providing networking events and investment facilitation for Victorian companies.
- Jumpstart, Medtech Innovator, A*StarminorInternational medtech accelerators and government partners collaborating on Singapore trade mission program.
- WilamcoreOnline health technologies platform operated by BioMelbourne Network serving 7,000+ professionals with networking and resource capabilities.
Scale indicators6 records
Recent moves6 records
Expansion highlights5 records
BioMelbourne Network competitors and assessment
Company assessmentDirect peers
- ANDHealth:
- Pathology Technology Australia: Australian industry body representing the in-vitro diagnostics and pathology technology sector. Directly comparable as a membership-based industry association representing health technology manufacturers and service providers, and a joint advocacy partner on R&D Tax Incentive issues.
- MTPConnect: Australian Government-funded MedTech and Pharma Growth Centre, operating as an industry connector for the sector. Directly comparable as a peak body driving collaboration, events, and policy advocacy across Australia's medical technology and pharmaceutical sectors, and a co-signatory with BioMelbourne on national policy submissions.
- ARCS Australia: Australia's peak industry body for the clinical research, pharmaceutical, and medical device sectors. Directly comparable as a membership association providing professional development, advocacy, and sector events for organisations across the health technology value chain, and a fellow co-signatory on BioMelbourne's policy submissions.
- AusBiotech: Australia's national biotechnology industry association. Directly comparable as a membership-based industry body serving biotech, medtech, and health tech companies across Australia, and BioMelbourne's principal co-advocacy partner on R&D Tax Incentive issues.
Regional players
- MedCity: London-based life sciences cluster organisation supporting health technology and medtech companies in the greater London region. Comparable as a cluster-based industry body with a similar mission of connecting companies, research, and capital in a defined geographic health tech ecosystem, but operating in a different geography.
- Life Sciences WA: Western Australia's peak industry body for the life sciences sector. Comparable to BioMelbourne Network as a state-level Australian membership association for health technologies, but operating in a different geography (WA) and not directly competing for Victorian members.
- Life Sciences Queensland: Queensland's peak industry body for life sciences and health technologies. Closely comparable to BioMelbourne Network as a state-level membership association, but operating in a different Australian state and therefore not in direct competition for Victorian members.
- BioNSW: New South Wales' industry association for the biotechnology and life sciences sector. Comparable as a state-level Australian membership body serving biotech and health tech organisations, but focused on NSW-based members and therefore a regional rather than direct competitor.
Broad incumbents
- MassBio: Massachusetts' state-level biotechnology industry association, one of the largest and most established US life sciences industry bodies. Comparable as a broader incumbent offering a more comprehensive suite of member services, policy advocacy, and events, and serving as a benchmark model for the kind of regional life sciences association BioMelbourne aspires to be.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
BioMelbourne Network social profiles
Digital presenceBioMelbourne Network financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioMelbourne Network leadership team
Management profileNumber of profiles
Profiles4 records
BioMelbourne Network funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioMelbourne Network M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioMelbourne Network
What does BioMelbourne Network do?
BioMelbourne Network is a not-for-profit, industry-led membership association that connects biotechnology, medical technology, and health innovation organisations in Victoria, Australia. It sells tiered annual memberships and delivers networking events, advocacy, and online community platforms (Wilam, BioResource Hub, Careers Hub) that foster collaboration, commercialisation, and policy engagement across the state's health technology ecosystem.
Is BioMelbourne Network a public or private company?
BioMelbourne Network is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was BioMelbourne Network founded?
BioMelbourne Network was founded in 2001. It employs 1 to 10 people.
Where is BioMelbourne Network based?
BioMelbourne Network is headquartered in Melbourne, Australia, in the Oceania region.
How does BioMelbourne Network make money?
Three revenue lines are on record. Membership Fees are the primary driver. The others are event Registration Fees and event Sponsorship.
Who are BioMelbourne Network's main competitors?
Direct peers on record are ANDHealth, Pathology Technology Australia, MTPConnect, ARCS Australia and AusBiotech. Regional players are MedCity, Life Sciences WA, Life Sciences Queensland and BioNSW. MassBio is listed as a broad incumbent.
Does BioMelbourne Network have an API?
No public API is recorded for BioMelbourne Network.
What industry is BioMelbourne Network in?
BioMelbourne Network's product category is Health Technology Industry Association. Its primary akta.pro industry code is THAHAJAB, Life Sciences & Biotechnology Congresses. Its NAICS code is 813 and its SIC code is 8600.